Odonate Therapeutics Inc (ODT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ODT Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Odonate Therapeutics Inc adapts its asset base and funding mix.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2021)
(Jun 30 2021) (Mar 31 2021) (Dec 31 2020) (Sep 30 2020)
Assets
Cash & cash equivalent95.03
Cash & Short-term Investments95.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current4.55
Total Current Assets99.58
Equipment/Property/Plant Net1.83
Other Assets, Noncurrent2.00
Operating Lease Right Of Use Asset3.59
Restricted Cash Noncurrent0.71
Total Assets105.77
Liabilities
Accounts Payable, Current AC11.66
Accrued Liabilities, Current AC17.89
Other Liabilities, Current0.74
Total Current Liabilities30.30
Total Long-term Debt0.00
Other liabilities, Noncurrent4.11
Operating Lease Liability Current0.74
Operating Lease Liability Noncurrent4.11
Total Liabilities34.40
Stockholders' Equity
Common Stock Value0.37
Additional Paid In Capital Common Stock507.21
Retained Earnings / Accumulated Deficit-436.21
Other Equity0.00
Common Stockholder's Equity71.37
Total Stockholder's Equity71.37
Liabilities & Stockholder's Equity105.77
4 historic quarters locked

Sign in to unlock the full Odonate Therapeutics Inc balance sheet history.

About ODT Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.